A Phase I II Study of GMI-1271, a Novel E-selectin Antagonist, in Combination with Induction Chemotherapy in Relapsed Refractory and Previously Untreated Elderly Patients with Acute Myeloid Leukemia; Results to Date Dan - substantial equivalence - Document - PDFSEARCH.IO

First Page		Document Content
Date: 2016-12-05 13:18:26		A Phase I/II Study of GMI-1271, a Novel E-selectin Antagonist, in Combination with Induction Chemotherapy in Relapsed/Refractory and Previously Untreated Elderly Patients with Acute Myeloid Leukemia; Results to Date Dan Add to Reading List Source URL: glycomimetics.com Download Document from Source Website File Size: 1,05 MB Share Document on Facebook